JP2023552274A5 - - Google Patents
Info
- Publication number
- JP2023552274A5 JP2023552274A5 JP2023526237A JP2023526237A JP2023552274A5 JP 2023552274 A5 JP2023552274 A5 JP 2023552274A5 JP 2023526237 A JP2023526237 A JP 2023526237A JP 2023526237 A JP2023526237 A JP 2023526237A JP 2023552274 A5 JP2023552274 A5 JP 2023552274A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound according
- patients
- deuterium
- herpes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20204545.6 | 2020-10-29 | ||
| EP20204545 | 2020-10-29 | ||
| PCT/EP2021/080023 WO2022090409A1 (en) | 2020-10-29 | 2021-10-28 | Deuterated aminothiazole compounds as antiviral compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552274A JP2023552274A (ja) | 2023-12-15 |
| JP2023552274A5 true JP2023552274A5 (enExample) | 2024-10-22 |
Family
ID=73037895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526237A Pending JP2023552274A (ja) | 2020-10-29 | 2021-10-28 | 抗ウイルス化合物としての重水素化アミノチアゾール化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12552756B2 (enExample) |
| EP (1) | EP4237414A1 (enExample) |
| JP (1) | JP2023552274A (enExample) |
| KR (1) | KR20230131177A (enExample) |
| CN (1) | CN116783171A (enExample) |
| AU (1) | AU2021367976A1 (enExample) |
| CA (1) | CA3196645A1 (enExample) |
| MX (1) | MX2023004955A (enExample) |
| WO (1) | WO2022090409A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4466255A1 (en) | 2022-01-17 | 2024-11-27 | Innovative Molecules GmbH | Solid crystalline forms of helicase-primase inhibitors and process of preparation thereof |
| IL325911A (en) | 2023-07-17 | 2026-03-01 | Innovative Molecules Gmbh | Micronized crystalline hydrochloride salts of antiviral helicase-primase inhibitor compounds |
| WO2026078039A1 (en) | 2024-10-09 | 2026-04-16 | Innovative Molecules Gmbh | Oral administration forms of antiviral helicase-primase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DOP2000000109A (es) * | 1999-12-23 | 2002-08-30 | Gerald Kleymann | Derivados de tiazolilamida |
| GEP20207128B (en) * | 2016-04-06 | 2020-07-10 | Molecules Gm Innovative | Aminothiazole derivatives useful as antiviral agents |
| MX2020003369A (es) * | 2017-10-05 | 2020-07-29 | Innovative Molecules Gmbh | Enantiomeros de tiazoles sustituidos como compuestos antivirales. |
| TW202038947A (zh) | 2018-11-28 | 2020-11-01 | 德商創新分子有限責任公司 | 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑 |
-
2021
- 2021-10-28 KR KR1020237017885A patent/KR20230131177A/ko active Pending
- 2021-10-28 US US18/034,099 patent/US12552756B2/en active Active
- 2021-10-28 CA CA3196645A patent/CA3196645A1/en active Pending
- 2021-10-28 AU AU2021367976A patent/AU2021367976A1/en active Pending
- 2021-10-28 WO PCT/EP2021/080023 patent/WO2022090409A1/en not_active Ceased
- 2021-10-28 JP JP2023526237A patent/JP2023552274A/ja active Pending
- 2021-10-28 EP EP21802293.7A patent/EP4237414A1/en active Pending
- 2021-10-28 CN CN202180088642.XA patent/CN116783171A/zh active Pending
- 2021-10-28 MX MX2023004955A patent/MX2023004955A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023552274A5 (enExample) | ||
| ES2203615T3 (es) | Nucleosidos terapeuticos. | |
| JP2875814B2 (ja) | 治療用ヌクレオシド類 | |
| RU2006109491A (ru) | Новые трициклические нуклеозиды или нуклеотиды в качестве терапевтических средств | |
| JP2020183410A5 (enExample) | ||
| IL273681B2 (en) | Enantiomers of thiazoles are converted as antiviral compounds | |
| JP5271913B2 (ja) | 化合物 | |
| KR100270806B1 (ko) | 5-플루오로-2`-데옥시-3`-티아시티딘을 함유하는 b형 간염 치료를 위한 약제 | |
| PT96321B (pt) | Processo para a preparacao de nucleosidos de purina | |
| JP2021500394A5 (enExample) | ||
| CA2904692A1 (en) | Modified 4'-nucleosides as antiviral agents | |
| JP2022550454A5 (enExample) | ||
| EP0468119A1 (en) | Novel carbocyclic analogs of certain nucleosides | |
| JPH05509307A (ja) | プリンの抗ウイルス性ホスホノ―アルケン誘導体 | |
| JP2024170457A5 (enExample) | ||
| HUT68445A (en) | Antiviral nucleoside analogues | |
| Isobe et al. | Synthesis and structure–activity relationships of 2-substituted-8-hydroxyadenine derivatives as orally available interferon inducers without emetic side effects | |
| JP2010509205A5 (enExample) | ||
| JPH07504666A (ja) | プリン類似化合物の抗ウイルス性ホスホン酸誘導体 | |
| JP2013523717A5 (enExample) | ||
| JP2017522383A5 (enExample) | ||
| JP2014532636A5 (enExample) | ||
| EP0479822B1 (en) | Therapeutic nucleosides | |
| EP0398230A2 (en) | Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinoside monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate | |
| JP2007516296A5 (enExample) |